GLP-1s may be a worthwhile investment, but their value depends on how they are implemented and supported
In addition, as new agents enter the market, payer coverage and prior-authorization landscapes will shiftespecially with expanded medication benefits
Compounded Medications Prescribed Online Personalized Weight Management Free evaluations offered for many of our treatments
The results of clinical trials indicate that this may make it more effective for weight loss when compared to otherapproved drugs like Wegovy (semaglutide), which targets one hormone, and Mounjaro (tirzepatide), which targets two
Currently, GLP-1 agonist molecules are also prescribed off-label for obesity conditions
Noom has received multiple grants from the NIH for digital health research and innovation and has been recognized by the CDC for its groundbreaking diabetes prevention programs